Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Thomas Bengtsson
A Dose-Ranging Study of the Inhaled Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine in COPD
Respiratory Research
Pulmonary
Respiratory Medicine
Related publications
Inhaled Corticosteroids in Ventilated Preterm Neonates: A Non-Randomized Dose-Ranging Study
BMC Pediatrics
Child Health
Pediatrics
Perinatology
Stepwise Withdrawal of Inhaled Corticosteroids in COPD Patients Receiving Dual Bronchodilation: WISDOM Study Design and Rationale
Respiratory Medicine
Pulmonary
Respiratory Medicine
Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis
Rheumatology and Therapy
Concentration–QT Modeling Following Inhalation of the Novel Inhaled Phosphodiesterase‐4 Inhibitor CHF6001 in Healthy Volunteers Shows an Absence of QT Prolongation
CPT: Pharmacometrics and Systems Pharmacology
Modeling
Simulation
Cardiovascular Medicine
Pharmacology
Cardiology
Stable COPD: Predicting Benefit From High-Dose Inhaled Corticosteroid Treatment
Yearbook of Medicine
Pharmacological Profile of GPD-1116, an Inhibitor of Phosphodiesterase 4
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Treatment of Diaphragmatic Fatigue With Inhaled Aminophylline Therapy in an Experimental Canine Model: An Open-Label, Dose-Ranging, Pharmacologic Study
Current Therapeutic Research
Pharmacology
A Case of Pityriasis Rubra Pilaris Treated Successfully With the Phosphodiesterase-4 Inhibitor Apremilast
Acta Dermato-Venereologica
Dermatology
Medicine
Inhaled Corticosteroid Use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT Study
Lung
Pulmonary
Respiratory Medicine